Speaker Profile

Ph.D., Vice President of Sales and Marketing, Myriad RBM, Inc.
Biography

Dr. Eisinger is a member of the executive management team at Myriad RBM, a leading multiplexed immunoassay testing laboratory providing comprehensive protein biomarker services for drug development within a CLIA certified laboratory. He directs sales, marketing, and business development in the therapeutic areas of immuno-oncology, oncology, autoimmune, metabolic, CNS and CVD applications. Dr. Eisinger joined Myriad RBM in 2006 when RBM acquired Multiplex Biosciences, a multiplex immunoassay development and manufacturing company he started and lead as President and CEO. He has over 22 years of industry leadership experience in various R&D, operational, and commercialization roles. Dr. Eisinger has B.S. in biochemistry from Cornell University and a PhD in stem cell molecular biology from the University of Vermont prior to completing post-doctoral training at Dartmouth Medical School.

Immunotherapy Showcase: Myriad RBM, Inc.
Myriad RBM, Inc. is a CLIA certified, multiplexed immunoassay testing laboratory.

Circulating IL-8: A New Response Predictor for Immunotherapies
Utilizing 2 immunoassay platforms validated to clinical laboratory standards for quantifying circulating proteins from immunotherapy clinical trial patients, select pharmacodynamic and prognostic biomarker findings will be presented including the discovery of IL-8 as a biomarker and therapy target.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

You have Successfully Subscribed!